India’s health spend just over 1% of GDP

NEW DELHI: India currently spends a little over 1% of GDP on health, far below Singapore which has the lowest public spend on health at 2.2% of GDP among countries with significant universal health coverage (UHC) service, according latest National Health Profile (NHP) data.

India’s per capita public expenditure on health increased from Rs 621 in 2009-10 to Rs 1,112 (around $16 at current exchange rate) in 2015-16. However, it is still “nominal”, compared to other countries. Switzerland spends $6944 on health per capita, whereas the US spends $4802 and UK spends$3500.

India’s health spend just over 1% of GDP
But this could change as the centre plans to launch its ambitious National Health Protection Schem (NHPS)- Ayushman Bharat – to cover over 10 crore poor families with an annual health cover of Rs 5 lakh per family. Modicare, as it is called, is billed to be the world’s largest such government-run insurance scheme.

According to NHP (2018), around 43 crore individuals or 34% of the population were covered under any health insurance in 2016-17. Launching the NHP, health minister JP Nadda said NHPS will significantly bring down the out of pocket expenditure on health.

Though the latest NHP data do not give figures for ‘out of pocket’ expenditure, WHO’s health financing profile for 2017 shows 67.78% of total expenditure on health in India was paid out of pocket. The world average is 18.2%.

Total public expenditure on health in 2015-16 was Rs 140,054 crore.

  • Related Posts

    Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

    Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

    Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

    Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

    Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

    Novartis wins approval for first malaria drug for newborns and babies

    Novartis wins approval for first malaria drug for newborns and babies

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr